NFE2L2 and hepatocellular carcinoma: TRIM25 expression was found positively associated with NRF2 expression in hepatocellular carcinoma, mechanistically, TRIM25 directly targeted Keap1 by ubiquitination and degradation, leading to NRF2 activation (44).